Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor (Q36988001)

From Wikidata
Jump to navigation Jump to search
scientific article published on July 2013
edit
Language Label Description Also known as
English
Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor
scientific article published on July 2013

    Statements

    Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor (English)
    Dagmar Kubitza
    Angelika Roth
    Michael Becka
    Abir Alatrach
    Atef Halabi
    Holger Hinrichsen
    Wolfgang Mueck
    1 July 2013
    89-98

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit